Full Length Research Paper
Abstract
The β-asarone was a major component of Acorus tatarinowii Schott which had significant pharmacological effects on the central nervous system (CNS). We have reported that β-asarone can pass through the blood-brain barrier (BBB) and then go into the brain tissues in the 2002. However, the β-asarone in the brain blood was not excluded, which might lead to a false positive result. In this study, we used the cardio-perfusion method to exclude the β-asarone in the brain blood then examined the brain tissues with gas chromatography–mass spectrometry (GC-MS). Meanwhile we hypothesized that the β-asarone could be widely distributed without target regions in the brain. To test this hypothesis, we analyzed the distribution of β-asarone in rat hippocampus, brainstem, cortex and cerebellum. We found that β-asarone could be detected in rat hippocampus, brainstem, cortex and cerebellum but the β-asarone amount was less than our previous results, which indicated the β-asarone in brain blood had affected the assay of β-asarone in the brain tissues. Meanwhile, we found that distribution of β-asarone among the hippocampus, brainstem, cortex and cerebellum did not have significant differences. We concluded that β-asarone could pass through BBB and be widely distributed without target regions in the brain.
Key words: Distribution of β-asarone, Acorus tatarinowii Schott, hippocampus, brainstem, cortex, cerebellum, gas chromatography–mass spectrometry (GC-MS).
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0